Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicenter Study Comparing the Safety and Efficacy of CT-ACL001, a Regenerative Ligament, With Standard Treatment in Anterior Cruciate Ligament Reconstruction

NCT07129694 is registered in ClinicalTrials.gov with CoreTissue BioEngineering Inc. as lead sponsor.

NCT NCT07129694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07129694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicenter Study Comparing the Safety and Efficacy of CT-ACL001, a Regenerative Ligament, With Standard Treatment in Anterior Cruciate Ligament Reconstruction
Lead sponsor
CoreTissue BioEngineering Inc.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
November 25, 2024
Completion date
November 30, 2027
Enrollment
64 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament rupture